Novavax Inc said on Wednesday it has signed an agreement with the Australian Government to supply 40 million doses of the its Covid-19 vaccine candidate, NVX-CoV2373, according to Reuters.
Under the agreement, the company will deliver its vaccine to Australia starting as early as the first half of 2021, Novavax said.
The company added it expects to report late-stage data from its UK trial as soon as the first quarter of 2021.
